Literature DB >> 2970517

Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

C Bottino1, G Tambussi, S Ferrini, E Ciccone, P Varese, M C Mingari, L Moretta, A Moretta.   

Abstract

Two mAbs directed to the TCR-gamma/delta were analyzed for their pattern of reactivity with CD3+WT31- cell populations or clones. In normal individuals, the BB3 mAb reacted with approximately 2/3 of peripheral blood CD3+WT31- lymphocytes, whereas delta-TCS-1 stained approximately 1/3 of such cells. In addition, the sum of the percentages of BB3+ and delta-TCS-1+ cells approximated the percentages of peripheral blood CD3+WT31- lymphocytes in seven normal donors tested. Also, in peripheral blood-derived polyclonal CD3+WT31- populations, cultured in IL-2, cells reacting with one or another mAb accounted for the whole cell population. On the other hand, only delta-TCS-1-reactive cells, but not BB3+ cells, could be detected in unfractionated as well as in CD4-8-thymocyte populations. Analysis of peripheral blood-derived CD3+WT31- clones showed that 70% of 72 clones analyzed reacted with BB3 mAb, but not with delta-TCS-1 mAb. On the other hand, delta-TCS-1 mAb stained the remaining BB3- clones. Five clones expressing medium-low amounts of CD8 antigen were BB3- delta-TCS-1+. Both types of clones lysed the Fc gamma receptor-bearing P815 target cell in the presence of anti-CD3 mAb (but not of mAb directed against HLA-DR, CD7 molecules, or TCR-alpha/beta). In this cytolytic assay, BB3 mAb induced target cell lysis only by BB3+ clones, whereas delta-TCS-1 mAb was effective only with delta-TCS-1+ clones. The CD3-associated surface molecules expressed by BB3+ or delta-TCS-1+ clones were analyzed after cell surface iodination and immunoprecipitation with the corresponding anti-TCR mAb or with anti-CD3 mAb (in digitonin-containing buffer). In SDS-PAGE, molecules immunoprecipitated from 13 BB3+ clones displayed, under nonreducing conditions, a molecular weight of 80 kD (in some cases, a minor 38-kD band could be detected). Under reducing conditions, two major components of 44 and 41 kD (and a minor component of 38 kD) were detected. On the other hand, TCR molecules immunoprecipitated from 11 different delta-TCS-1+ clones appeared as a diffuse band of 41-44 kD, both under reducing and nonreducing conditions (under non-reducing condition, an additional 38-kD band was present). Therefore, BB3+ cells express a disulphide-linked form of TCR-gamma/delta whereas delta-TCS-1+ cells express a non-disulphide-linked form.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970517      PMCID: PMC2189015          DOI: 10.1084/jem.168.2.491

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  36 in total

1.  Limited diversity of the rearranged T-cell gamma gene.

Authors:  D M Kranz; H Saito; M Heller; Y Takagaki; W Haas; H N Eisen; S Tonegawa
Journal:  Nature       Date:  1985 Feb 28-Mar 6       Impact factor: 49.962

2.  Cross-linking of human T cell receptor proteins: association between the T cell idiotype beta subunit and the T3 glycoprotein heavy subunit.

Authors:  M B Brenner; I S Trowbridge; J L Strominger
Journal:  Cell       Date:  1985-01       Impact factor: 41.582

3.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line.

Authors:  A Weiss; J D Stobo
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

4.  Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences.

Authors:  H Saito; D M Kranz; Y Takagaki; A C Hayday; H N Eisen; S Tonegawa
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

5.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

6.  Structure, organization, and somatic rearrangement of T cell gamma genes.

Authors:  A C Hayday; H Saito; S D Gillies; D M Kranz; G Tanigawa; H N Eisen; S Tonegawa
Journal:  Cell       Date:  1985-02       Impact factor: 41.582

7.  Comparison of T3-associated 49- and 43-kilodalton cell surface molecules on individual human T-cell clones: evidence for peptide variability in T-cell receptor structures.

Authors:  E L Reinherz; S C Meuer; K A Fitzgerald; R E Hussey; J C Hodgdon; O Acuto; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

8.  The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides.

Authors:  J Kappler; R Kubo; K Haskins; C Hannum; P Marrack; M Pigeon; B McIntyre; J Allison; I Trowbridge
Journal:  Cell       Date:  1983-11       Impact factor: 41.582

9.  Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells.

Authors:  A L Hubbard; Z A Cohn
Journal:  J Cell Biol       Date:  1975-02       Impact factor: 10.539

10.  A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s).

Authors:  E Ciccone; S Ferrini; C Bottino; O Viale; I Prigione; G Pantaleo; G Tambussi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1988-07-01       Impact factor: 14.307

View more
  62 in total

1.  Preferential activation of peripheral blood V gamma 9+ gamma/delta T cells by group A, B and C but not group D or F streptococci.

Authors:  A Bender; D Kabelitz
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 2.  TCR gamma delta cells: antigen-driven expansion of distinct subsets based on localization and antigen specificity.

Authors:  P M Kluin; C J Rust; M L Mearin; A S Peña; F Koning
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Growth features of T-cell receptor gamma/delta-positive cell clones.

Authors:  G Arancia; W Malorni; F Iosi; D Zarcone; G Cerruti; A Moretta; C E Grossi
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 4.  Newly identified gamma delta and beta delta T-cell receptors.

Authors:  F Hochstenbach; M B Brenner
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

5.  Gamma delta T-cell receptor repertoire in human peripheral blood and thymus.

Authors:  H Vietor; F Koning
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

6.  Selective gamma-chain T-cell receptor gene rearrangements in a patient with Omenn's syndrome: absence of V-II subgroup (V gamma 9) transcripts.

Authors:  G Mathioudakis; R A Good; Y Chernajovsky; N K Day; C D Platsoucas
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

7.  Molecular heterogeneity of gamma delta T-cell antigen receptors expressed by CD4- CD8- T-cell clones from normal donors: both disulfide- and non-disulfide-linked receptors are delta TCS1+.

Authors:  H Seki; M Nanno; P F Chen; K Itoh; C Ioannides; R A Good; C D Platsoucas
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

8.  Restriction of the T-cell receptor V delta gene repertoire is due to preferential rearrangement and is independent of antigen selection.

Authors:  N Migone; S Padovan; C Zappador; C Giachino; M Bottaro; G Matullo; C Carbonara; G D Libero; G Casorati
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

9.  Immunohistochemical study of gamma delta T cell receptor-positive cells in the capsular region of hepatocellular carcinoma: possible role in defense against expansion of carcinoma in the liver.

Authors:  K Chin; K Morise; K Kanayama; H Nagura
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

10.  Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease.

Authors:  L Wen; M Peakman; G Mieli-Vergani; D Vergani
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.